Rice Hall James & Associates, LLC Abbott Laboratories Transaction History

Rice Hall James & Associates, LLC

  • $1.69 Billion
  • Q2 2025

A detailed history of Rice Hall James & Associates, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 6,179 shares of ABT stock, worth $809,572. This represents 0.05% of its overall portfolio holdings.

Number of Shares
6,179
Previous 5,553 11.27%
Holding current value
$809,572
Previous $736,000 14.13%
% of portfolio
0.05%
Previous 0.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$123.95 - $138.08 $77,592 - $86,438
626 Added 11.27%
6,179 $840,000
Q1 2025

May 01, 2025
BUY
$111.1 - $140.22 $60,549 - $76,419
545 Added 10.88%
5,553 $736,000
Q3 2024

Oct 28, 2024
SELL
$100.07 - $118.13 $3,802 - $4,488
-38 Reduced 0.75%
5,008 $570,000
Q1 2024

Apr 23, 2024
SELL
$109.52 - $120.96 $9,856 - $10,886
-90 Reduced 1.75%
5,046 $573,000
Q3 2023

Nov 02, 2023
SELL
$95.53 - $114.62 $14,329 - $17,193
-150 Reduced 2.84%
5,136 $497,000
Q2 2023

Jul 24, 2023
SELL
$100.78 - $112.29 $10,078 - $11,229
-100 Reduced 1.86%
5,286 $576,000
Q4 2022

Jan 27, 2023
SELL
$95.06 - $111.52 $133,084 - $156,128
-1,400 Reduced 20.63%
5,386 $0
Q3 2022

Nov 01, 2022
SELL
$96.76 - $112.03 $14,514 - $16,804
-150 Reduced 2.16%
6,786 $657,000
Q1 2022

May 05, 2022
SELL
$114.02 - $139.04 $77,533 - $94,547
-680 Reduced 8.93%
6,936 $821,000
Q4 2021

Feb 14, 2022
SELL
$115.53 - $141.46 $11,553 - $14,146
-100 Reduced 1.3%
7,616 $1.07 Million
Q3 2021

Nov 09, 2021
SELL
$116.66 - $129.06 $34,998 - $38,718
-300 Reduced 3.74%
7,716 $911,000
Q1 2021

May 14, 2021
SELL
$108.84 - $128.23 $11,972 - $14,105
-110 Reduced 1.35%
8,016 $961,000
Q4 2020

Feb 16, 2021
SELL
$105.0 - $114.42 $5,250 - $5,721
-50 Reduced 0.61%
8,126 $890,000
Q2 2020

Aug 14, 2020
SELL
$76.57 - $98.0 $45,941 - $58,800
-600 Reduced 6.84%
8,176 $748,000
Q1 2020

May 15, 2020
SELL
$62.82 - $91.86 $46,989 - $68,711
-748 Reduced 7.85%
8,776 $693,000
Q1 2019

May 01, 2019
SELL
$66.22 - $80.06 $26,488 - $32,024
-400 Reduced 4.03%
9,524 $761,000
Q4 2018

Feb 14, 2019
SELL
$65.56 - $74.27 $338,486 - $383,456
-5,163 Reduced 34.22%
9,924 $718,000
Q2 2018

Aug 02, 2018
SELL
$57.57 - $63.54 $28,785 - $31,770
-500 Reduced 3.21%
15,087 $920,000
Q1 2018

Apr 25, 2018
SELL
$56.27 - $63.62 $2,813 - $3,181
-50 Reduced 0.32%
15,587 $934,000
Q4 2017

Jan 23, 2018
SELL
$53.68 - $57.47 $54,109 - $57,929
-1,008 Reduced 6.06%
15,637 $892,000
Q3 2017

Oct 30, 2017
BUY
$48.06 - $53.64 $799,958 - $892,837
16,645
16,645 $888,000

Others Institutions Holding ABT

# of Institutions
3,580
Shares Held
1.39B
Call Options Held
9.73M
Put Options Held
9.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $229B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email